San Diego, CA, United States of America

Philippe A Parone

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Philippe A Parone in Immunology

Introduction

Philippe A Parone is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of immunology, particularly in the development of methods for inducing myeloid suppressive cells. His work focuses on enhancing therapeutic potential for various medical conditions.

Latest Patents

Philippe A Parone holds a patent titled "Composition and methods for inducing myeloid suppressive cells and use thereof." This patent encompasses compositions and methods for manufacturing induced immune regulatory cells, including myeloid-derived suppressor cells (MDSCs), dendritic cells, and macrophages. The patent also details methods for further modifying these cells to improve their therapeutic efficacy in treating autoimmune disorders, hematological malignancies, solid tumors, viral infections, neurodegenerative disorders, inflammatory conditions, and graft-versus-host disease (GvHD).

Career Highlights

Philippe A Parone is currently associated with Fate Therapeutics, Inc., where he continues to innovate in the field of immunotherapy. His work is pivotal in advancing treatments that leverage the body's immune system to combat various diseases.

Collaborations

He collaborates with notable colleagues, including Robert S Tacke and Bahram Valamehr, who contribute to the research and development efforts at Fate Therapeutics, Inc.

Conclusion

Philippe A Parone's innovative work in immunology, particularly through his patent on myeloid suppressive cells, showcases his commitment to advancing medical science. His contributions are vital for developing new therapies that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…